Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBK
576
DELISTED
Westpac Banking Corporation
WBK
| $32.1M | 0.04% |
1,373,206
+103,906
| +8% | +$2.52M |
|
577
8x8 Inc
EGHT
$303M
| $32.1M | 0.04% |
2,206,430
+388,000
| +21% | +$5.5M |
|
578
Lockheed Martin
LMT
$138B
| $32.1M | 0.04% |
115,500
+55,000
| +91% | +$15.1M |
|
579
US Foods
USFD
$23.8B
| $32.1M | 0.04% |
+1,177,600
| New | +$33.5M |
|
580
Novanta
NOVT
$6.33B
| $32.1M | 0.04% |
890,300
+110,800
| +14% | +$3.52M |
|
|
KYO
581
DELISTED
Kyocera Adr
KYO
| $32M | 0.04% |
549,600
+13,910
| +3% | +$802K |
|
582
Hain Celestial
HAIN
$53.9M
| $32M | 0.04% |
824,522
+77,900
| +10% | +$2.81M |
|
|
CEO
583
DELISTED
CNOOC Limited
CEO
| $31.9M | 0.04% |
291,400
+117,300
| +67% | +$13.5M |
|
584
MKS Inc
MKSI
$20.7B
| $31.8M | 0.04% |
+472,852
| New | +$35.8M |
|
585
New York Times
NYT
$10.3B
| $31.7M | 0.04% |
1,793,500
+183,000
| +11% | +$3.01M |
|
|
NORD
586
DELISTED
Nord Anglia Education, Inc.
NORD
| $31.7M | 0.04% |
974,585
+812,385
| +501% | +$25.3M |
|
587
Prologis
PLD
$134B
| $31.7M | 0.04% |
540,500
-119,171
| -18% | -$6.64M |
|
588
Green Dot
GDOT
$770M
| $31.7M | 0.04% |
821,842
+299,842
| +57% | +$10.8M |
|
589
Corcept Therapeutics
CORT
$11.9B
| $31.7M | 0.04% |
2,683,400
+824,900
| +44% | +$8.97M |
|
590
LyondellBasell Industries
LYB
$20.2B
| $31.6M | 0.04% |
+374,000
| New | +$31.1M |
|
|
P
591
Everpure Inc
P
$39B
| $31.5M | 0.04% |
2,461,000
+1,177,000
| +92% | +$13.7M |
|
592
First Merchants
FRME
$2.72B
| $31.5M | 0.04% |
785,329
+24,000
| +3% | +$968K |
|
|
CUTR
593
DELISTED
Cutera, Inc.
CUTR
| $31.5M | 0.04% |
1,214,500
+9,100
| +0.8% | +$199K |
|
594
CoreCivic
CXW
$3.13B
| $31.4M | 0.04% |
1,140,003
+216,400
| +23% | +$6.76M |
|
595
Landstar System
LSTR
$6.4B
| $31.4M | 0.04% |
366,340
+154,000
| +73% | +$13M |
|
596
Herbalife
HLF
$1.28B
| $31.3M | 0.04% |
876,200
-1,436,200
| -62% | -$48.4M |
|
597
Advanced Energy
AEIS
$13.2B
| $31.2M | 0.04% |
482,022
+90,822
| +23% | +$6.64M |
|
598
Steel Dynamics
STLD
$37.3B
| $31.1M | 0.04% |
869,100
+569,400
| +190% | +$19.7M |
|
599
Weis Markets
WMK
$1.77B
| $31.1M | 0.04% |
637,600
+33,800
| +6% | +$1.86M |
|
600
AXIS Capital
AXS
$7.3B
| $31M | 0.04% |
480,100
+314,800
| +190% | +$20.5M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.